News for AIM ImmunoTech Inc. (0A4Y.L)

ARMISTICE CAPITAL, LLC (Trades, Portfolio), a notable investment firm, recently executed a significant transaction involving AIM ImmunoTech Inc. On December 31,

**media[516023]**

**media[495001]**

AIM ImmunoTech Announces Election of Three Incumbent Board Members at Annual Meeting

AIM ImmunoTech Reminds Shareholders to Vote FOR All Four Incumbent Board Members on the WHITE Universal Proxy Card

Kellner Group Denounces False Rumors About AIM Short Selling and Demands Immediate Accountability from Incumbent Board

Incumbent Board has Destroyed Stockholder Value and Imperiled AIM's Future through Breaches of Fiduciary Duty and Bad Faith Actions

Incumbent Board has Destroyed Stockholder Value and Imperiled AIM's Future through Breaches of Fiduciary Duty and Bad Faith Actions

Follows Announcement Earlier this Week that Ampligen Co-Founder and Former AIM CEO Agreed to Join Scientific Advisory Board if Kellner Group Nominees Are Electe

Follows Announcement Earlier this Week that Ampligen Co-Founder and Former AIM CEO Agreed to Join Scientific Advisory Board if Kellner Group Nominees Are Elected Kellner Group Reiterates Plan to Revitalize AIM, Accelerate Clinical Development and Restore Value for Stockholders

Incumbent Board's Claims of Progress Are Not Credible or Supported by DataAIM Maintains Relationship with CRO Co-Founded by a Convicted Felon Who Deceived Inves

ISS Recommends AIM ImmunoTech Shareholders Vote FOR Company Nominees Nancy K. Bryan and Dr. William M. Mitchell

Kellner Group Urges Stockholders of AIM Immunotech to Vote the Gold Card

Breach of Duties, Gross Waste and Lack of Transparency by Incumbent Board are Disqualifying Incumbent Board has Destroyed Stockholder Value and has No Plan for

Tailoring wart therapeutics to individual patients based on factors like wart type, location, and responsiveness to previous treatments can lead to more...

The Dow Jones closed higher by around 75 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Gainers Auddia Inc. (NASDAQ: AUUD) shares rose 103.2% to $0.8809 in pre-market trading after gaining around 9% on Friday.

Company’s SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical industry OCALA, Fla., April...

Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive sleep apnea.